Privacy Statement
This website is owned by Auxilium Pharmaceuticals, Inc. (“Auxilium”) and is operated by Auxilium and its selected technology partners, which have agreed to comply with this privacy policy.
This privacy policy is designed to tell you about our practices regarding collection, use and disclosure of information that you may provide via this site. Please be sure to read this privacy policy before using or submitting information to this website. This site is governed solely by applicable federal and state laws and governmental regulations in the United States. Use of this site constitutes your consent to application of such laws and regulations and to the terms of our privacy policy. Whenever you submit information via this site, you consent to the collection, use and disclosure of that information in accordance with this privacy policy.
Your use of this site is subject to our Terms of Use.
Notice of Information Collected
Like many websites, this site collects information from its visitors. Some information that you submit may be personally identifiable information (that is, information that can be uniquely identified with you, such as your full name, address, e-mail address, phone number and so on).
Some areas of this site may require you to submit information in order for you to benefit from the specified features. You will be informed at the information collection point what information is required.
As you navigate through a website, certain information can be passively collected (that is, gathered without your actively providing the information) using various technologies and means, such as Internet protocol addresses, cookies, Internet tags and navigational data collection.
Except as otherwise stated, the information we collect is used to improve the content of our website and may be used to communicate with you, via e-mail, regular mail or by other means, and to provide you with information that we believe to be of interest to you or that you have requested. In addition, we may use this information for marketing and research purposes. This information is for internal use only.
Transfer of Information Beyond Auxilium
We may disclose your personally identifiable information to other Auxilium affiliates worldwide that agree to treat it in accordance with this privacy policy. In addition, we may disclose your personally identifiable information where required by applicable laws, court orders or government regulations.
Access to Information
You may have access to your personal information at any time, to revise, correct or delete it, by contacting Auxilium. If at any time you do not wish Auxilium to contact you or if you have any questions concerning our privacy practices, please feel free to contact us http://www.auxilium.com/Global/ContactUs.aspx.
Protection of Your Personal Information
We take reasonable steps to protect your personally identifiable information as you transmit your information from your computer to our site and to protect such information from loss, misuse and unauthorized access, disclosure, alteration or destruction. You should keep in mind that no Internet transmission is ever 100% secure or error-free. In particular, e-mail sent to or from this site may not be secure, and you should therefore take care in deciding what information you send to us via e-mail. Moreover, where you use passwords, ID numbers or other special access features on this site, it is your responsibility to safeguard them.
Feedback Is Not Personal Information
Data that is not personal (such as feedback, questions, comments, ideas and suggestions) shall be deemed nonconfidential, and Auxilium shall be free to disclose and use such data without any obligation toward you.
Under no circumstances should you use this website to send Auxilium confidential or proprietary information. Auxilium does not want to receive such information.
By voluntarily submitting feedback to Auxilium, you are consenting to the above-noted Terms of Use.
Other Websites
This site may contain links or references to other websites. Please be aware that we do not control other websites and that this privacy policy does not apply to those websites. We encourage you to read the privacy policy of every website you visit.
Privacy Policy Updates
If this privacy policy changes, the revised policy will be posted on this site. Please check back periodically and especially before you provide any personally identifiable information. This privacy policy was last updated on October 9, 2009.
Indication
Testim 1% (testosterone gel) is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Important Safety Information
WARNING: SECONDARY EXPOSURE TO TESTOSTERONE
Virilization has been reported in children who were secondarily exposed to testosterone gel. Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel. Healthcare providers should advise patients to strictly adhere to recommended instructions for use.
Androgens are contraindicated in men with cancer of the breast or known or suspected cancer of the prostate. Testim is not indicated for women and must not be used in women. Pregnant and nursing women should avoid skin contact with Testim application sites on men. Testosterone may cause fetal harm, or harm a breast-feeding baby.
Testim should not be used in patients with known hypersensitivity to testosterone or any of the ingredients in Testim, including soy.
Men treated with androgens may be at an increased risk for prostate cancer, or the development or worsening of benign prostatic hyperplasia.
Testim is not meant for use in women. If you are pregnant, may become pregnant, or are breast-feeding, Testim may harm your unborn or breast-feeding baby. Women who are pregnant or who may become pregnant should avoid contact with the area where Testim has been applied.
Virilization can occur in women and children secondarily exposed to testosterone. To minimize the potential for secondary exposure to testosterone from Testim-treated skin, patients should wash their hands thoroughly and immediately with soap and water after application of Testim and should cover the application site(s) with clothing after the gel has dried. Prior to any situation in which direct skin-to-skin contact is anticipated, patients should wash the application sites thoroughly with soap and water so as to remove any testosterone residue.
Other risks associated with the use of testosterone include: edema with or without congestive heart failure, gynecomastia, and potentiation of sleep apnea. Large doses of testosterone may suppress spermatogenesis.
The most common adverse events occurring with the use of Testim include: application site reaction, increase in hematocrit/hemoglobin, headache, and increase in blood pressure.
Please see Full Prescribing Information and Medication Guide.